New QUINOLONE approved against ABSSSI. Let's remem
Post# of 72430
![Avatar](/images/ProfileImages/424989898_3046_Avatar jpeg2.jpg)
So great, glad there is something new to use, but, geeze, remember I've mentioned several times about someone I know who took ONE dose of Cipro and is now permanently disabled, in a wheelchair and having to take anti-seizure medications. ONE DOSE of Cipro.
So I'm not impressed by this new antibiotic. If Brilacidin for ABSSSI is approved, it will certainly be used first, before dangerous life-threatening quinolones are used.
Quote:
The FDA approves privately-held Melinta Therapeutics' Baxdela (delafloxacin), a fluoroquinolone antibiotic, for the treatment of adults with acute bacterial skin and skin structure infections ((ABSSSI)).
Baxdela had Qualified Infectious Disease Product (QIDP) status which provides for an additional five-year period of market exclusivity for the indication.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)